SMITH SEAN MICHAEL (Principal Accounting Officer) sold 17.2% of their position (3.32K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $2.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2023ACC: 0001209191-23-006886
Officer· Principal Accounting Officer
Since Mar 2022
-3.32K
Net shares
Net seller
$2.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 15.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
184.5%
2/1/2023
6.78K→19.28K
Common Stock
Direct
Shares
−3.32K
Price / share
$0.60
Trade value
$1.98K
% of position
17.2%
2/2/2023
19.28K→15.96K
Total
Net shares
+9.18K
Net value
-$1.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | M · Option Exercise | +12.50K | — | — | 184.5% | 6.78K | 19.28K |
| Common Stock Direct | 2/2/2023 | S · Sale | −3.32K | $0.60 | $1.98K | 17.2% | 19.28K | 15.96K |
| Total | +9.18K | -$1.98K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
0.00
Held after
12.50K
Exercisable
—
2/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.50K shares | 2/1/2023 | M · Option Exercise | −12.50K | 0.00 | — | 12.50K |